BloodHorse.com | Horse Racing News

Race-Day Medication Pros and Cons Debated

The pros and cons of race-day medication in racehorses were debated Nov. 14 during a lengthy meeting of the Kentucky Horse Racing Commission Race Day Medication Committee at the state Capitol.

Breed Integrity - By Eric Mitchell

What is the breeding
 industry's responsibility in identifying stallions with EIPH?

Read Blog

Study: EIPH is an Inherited Trait

A South African study showed a strong heritability between some stallions and exercise-induced pulmonary hemorrhaging, also known as bleeding.

Summit Digs Into Salix Use, Regulation

A well-attended summit June 13 at Belmont Park shed a lot of light on the research and international regulations surrounding the race-day medication Salix.

The Battle of Salix - By Eric Mitchell

The medication summit will shed plenty of light on how the U.S. can 
improve its policies.

Read Blog

Race-Day Medication Summit at Belmont Park

The first international summit on race-day medication as it relates to exercise-induced pulmonary hemorhaging will be June 13-14 at Belmont Park.

Jockey Club Strongly Urges Drug-Free Racing

Jockey Club president James Gagliano reiterates call for ban on race-day medications.

Study Shows Furosemide Has Beneficial Effects

A groundbreaking study to be published in the Journal of the American Veterinary Medical Association shows that furosemide does more than enhance performance in Thoroughbred racehorses; it also has beneficial effects on the health and welfare of those horses.

AAEP Requests Proposals for Bleeder Medication Research

The American Association of Equine Practitioners (AAEP) is seeking proposals to research the efficacy of adjunct bleeder medications, such as aminocaproic acid and/or conjugated estrogens, as a race day medication for prevention of exercise-induced pulmonary hemorrhage (EIPH).